Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...

It is formulated as a once-daily oral disintegrating tablet for sublingual administration, for ease of use in an elderly population. The firm’s ITI-333, a partial agonist of μ−opioid ...

Dissolve under tongue; do not chew or swallow. The use of buprenorphine HCl sublingual tablets for unsupervised administration should be limited to those patients who cannot tolerate buprenorphine ...

Exservan’s mode of administration, which requires no swallowing, can result in higher compliance and uptake among this patient group. "Aquestive maps out FDA approval for sublingual anaphylaxis ...